查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
頭頸癌診斷市場報告：2030 年趨勢、預測與競爭分析
市場調查報告書
商品編碼
1386078

頭頸癌診斷市場報告：2030 年趨勢、預測與競爭分析

Head and Neck Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

頭頸癌診斷的趨勢和預測

到 2030 年，全球頭頸癌診斷市場預計將達到 34 億美元，2024 年至 2030 年年複合成長率為 7.1%。市場的主要促進因素是頭頸癌盛行率不斷上升、獲得醫療保健的機會迅速增加、人們對頭頸癌體徵和症狀以及早期檢測重要性的認知不斷提高。全球頭頸癌診斷市場的未來前景看好，醫院、門診手術中心和診斷中心市場存在商機。

頭頸癌診斷市場洞察

Lucintel 預測診斷影像將在預測期內達到最高成長。

醫院將繼續成為該市場的最大細分市場，因為它們擁有更好的疾病診斷能力，並配備了最新的醫療設備和技術，為患者提供最佳的治療。

由於擁有強大的醫療基礎設施、有利的報銷政策、對該疾病的高度認知以及政府對醫療保健行業發展的支持，北美在預測期內可能仍然是最大的地區。

市場規模/估計：以金額的頭頸癌診斷市場規模估計（10 億美元）。

趨勢和預測分析：按細分市場和地區分類的市場趨勢（2018-2023）和預測（2024-2030）。

市場區隔分析：按類型、診斷、治療、最終用途和地區等各個細分市場估計頭頸癌診斷市場規模（十億美元）。

區域分析：北美、歐洲、亞太地區和世界其他地區頭頸癌診斷市場的區域細分。

成長機會：按類型、診斷、治療、最終用途和地區分析頭頸癌診斷市場的成長機會。

策略分析：頭頸癌診斷市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

常問問題

Q.1 頭頸癌診斷的市場規模有多大？

到2030 年，全球頭頸癌診斷市場預計將達到 34 億美元。

Q.2 頭頸癌診斷市場的成長預測如何？

答：到 2030 年，頭頸癌診斷市場預計將達到 34 億美元： 2024 年至 2030 年，全球頭頸癌診斷市場預計將以 7.1% 的年複合成長率成長。Masu。

Q.3 影響頭頸癌診斷市場成長的關鍵促進因素有哪些？

答：這個市場的主要驅動力是頭頸癌盛行率不斷上升、醫療保健普及率迅速增加、人們對頭頸癌體徵和症狀以及早期檢測重要性的認知不斷提高。

Q4. 頭頸癌診斷市場的主要細分市場有哪些？

答：頭頸癌診斷市場的前景看好，醫院、門診手術中心和診斷中心市場都有商機。

Q5. 頭頸癌診斷市場的主要企業有哪些？

答：頭頸癌診斷的主要企業有：

  • GE Healthcare
  • Philips
  • Siemens Healthineeer
  • Merck
  • Eli Lilly

Q6. 未來頭頸癌診斷哪個領域的市場規模最大？

答：Lucintel 預測診斷影像將在預測期內達到最高成長。

Q7. 在頭頸癌診斷市場中，預計未來年度哪個地區的市場規模最大？

由於強大的醫療基礎設施、有利的報銷政策、對疾病的高度認知以及政府對醫療保健行業發展的支持，北美在預測期內仍將是最大的地區。

Q.8 是否可以客製化報告？

答：是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

本報告回答了 11 個關鍵問題：

  • Q.1. 哪些細分市場最有前景和高成長機會？
  • Q.2. 哪個細分市場將以更快的速度成長？為什麼？
  • Q.3. 您認為哪些地區未來會出現更快的成長，為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6. 這個市場有哪些新趨勢？為什麼？
  • Q.7. 市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9. 誰是這個市場的主要企業？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11. 過去年度發生了哪些類型的併購，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球頭頸癌診斷市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球頭頸癌診斷市場趨勢（2018-2023）與預測（2024-2030）
  • 按類型分類的全球頭頸癌診斷市場
    • 喉癌
    • 咽癌
    • 唾液腺癌
    • 唇癌和口腔癌
    • 鼻咽癌
    • 其他
  • 全球頭頸癌診斷市場（按診斷）
    • 生物篩選試驗
    • 驗血
    • 牙科診斷
    • 影像
    • 內視鏡
  • 按治療分類的全球頭頸癌診斷市場
    • 化療
    • 放射治療
    • 標靶治療
    • 外科手術
    • 其他
  • 按最終用途分類的全球頭頸癌診斷市場
    • 醫院
    • 門診手術中心
    • 診斷中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 按地區分類的全球頭頸癌診斷市場
  • 北美頭頸癌診斷市場
  • 歐洲頭頸癌診斷市場
  • 亞太地區頭頸癌診斷市場
  • 其他地區頭頸癌診斷市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球頭頸癌診斷市場成長機會（按類型）
    • 全球頭頸癌診斷市場按診斷的成長機會
    • 全球頭頸癌診斷市場治療成長機會
    • 按最終用途分類的全球頭頸癌診斷市場的成長機會
    • 全球頭頸癌診斷市場按地區成長機會
  • 全球頭頸癌診斷市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球頭頸癌診斷市場的產能
    • 全球頭頸癌診斷市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • GE Healthcare
  • Philips
  • Siemens Healthineeer
  • Merck
  • Eli Lilly
簡介目錄

Head and Neck Cancer Diagnostic Trends and Forecast

The future of the global head and neck cancer diagnostic market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic center markets. The global head and neck cancer diagnostic market is expected to reach an estimated $3.4 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of head and neck cancer, surhing access to healthcare, and growing awareness of the signs and symptoms of head and neck cancer, as well as the importance of early detection.

A more than 150-page report is developed to help in your business decisions.

Head and Neck Cancer Diagnostic by Segment

The study includes a forecast for the global head and neck cancer diagnostic by type, diagnosis, treatment, end use, and region.

Head and Neck Cancer Diagnostic Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Laryngeal Cancer
  • Pharyngeal Cancer
  • Salivary Gland Cancer
  • Lip & Oral Cavity Cancer
  • Nasopharyngeal Cancer
  • Others

Head and Neck Cancer Diagnostic Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

  • Bioscopy Screening Tests
  • Blood Tests
  • Dental Diagnosis
  • Imaging
  • Endoscopy

Head and Neck Cancer Diagnostic Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Chemotherapy
  • Radiation Therapy
  • Targeted Therapy
  • Surgery
  • Others

Head and Neck Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others

Head and Neck Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Head and Neck Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies head and neck cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the head and neck cancer diagnostic companies profiled in this report include-

  • GE Healthcare
  • Philips
  • Siemens Healthineeer
  • Merck
  • Eli Lilly

Head and Neck Cancer Diagnostic Market Insights

Lucintel forecasts that imaging is expected to witness highest growth over the forecast period.

Within this market, hospitals will remain the largest segment because it has better disease diagnosis capabilities and also have the latest medical equipment and technology, which allows them to provide patients with the best possible care.

North America will remain the largest region during the forecast period due to the presence of a strong healthcare infrastructure, favorable reimbursement policies, high awareness about the disease, and government support for the development of the healthcare sector.

Features of the Global Head and Neck Cancer Diagnostic Market

Market Size Estimates: Head and neck cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Head and neck cancer diagnostic market size by various segments, such as by type, diagnosis, treatment, end use, and region in terms of ($B).

Regional Analysis: Head and neck cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, diagnosis, treatments, end uses, and regions for the head and neck cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the head and neck cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the head and neck cancer diagnostic market size?

Answer: The global head and neck cancer diagnostic market is expected to reach an estimated 3.4 billion by 2030.

Q.2 What is the growth forecast for head and neck cancer diagnostic market?

Answer: The global head and neck cancer diagnostic market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the head and neck cancer diagnostic market?

Answer: The major drivers for this market are increasing prevalence of head and neck cancer, surhing access to healthcare, and growing awareness of the signs and symptoms of head and neck cancer, as well as the importance of early detection.

Q4. What are the major segments for head and neck cancer diagnostic market?

Answer: The future of the head and neck cancer diagnostic market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic center markets.

Q5. Who are the key head and neck cancer diagnostic market companies?

Answer: Some of the key head and neck cancer diagnostic companies are as follows:

  • GE Healthcare
  • Philips
  • Siemens Healthineeer
  • Merck
  • Eli Lilly

Q6. Which head and neck cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that imaging is expected to witness highest growth over the forecast period.

Q7. In head and neck cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region during the forecast period due to the presence of a strong healthcare infrastructure, favorable reimbursement policies, high awareness about the disease, and government support for the development of the healthcare sector.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the head and neck cancer diagnostic market by type (laryngeal cancer, pharyngeal cancer, salivary gland cancer, lip & oral cavity cancer, nasopharyngeal cancer, and others), diagnosis (bioscopy screening tests, blood tests, dental diagnosis, imaging, and endoscopy), treatment (chemotherapy, radiation therapy, targeted therapy, surgery, and others), end use (hospitals, ambulatory surgical centers, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Head and Neck Cancer Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Head and Neck Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Head and Neck Cancer Diagnostic Market by Type
    • 3.3.1: Laryngeal Cancer
    • 3.3.2: Pharyngeal Cancer
    • 3.3.3: Salivary Gland Cancer
    • 3.3.4: Lip & Oral Cavity Cancer
    • 3.3.5: Nasopharyngeal Cancer
    • 3.3.6: Others
  • 3.4: Global Head and Neck Cancer Diagnostic Market by Diagnosis
    • 3.4.1: Bioscopy Screening Tests
    • 3.4.2: Blood Tests
    • 3.4.3: Dental Diagnosis
    • 3.4.4: Imaging
    • 3.4.5: Endoscopy
  • 3.5: Global Head and Neck Cancer Diagnostic Market by Treatment
    • 3.5.1: Chemotherapy
    • 3.5.2: Radiation Therapy
    • 3.5.3: Targeted Therapy
    • 3.5.4: Surgery
    • 3.5.5: Others
  • 3.6: Global Head and Neck Cancer Diagnostic Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Ambulatory Surgical Centers
    • 3.6.3: Diagnostic Centers
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Head and Neck Cancer Diagnostic Market by Region
  • 4.2: North American Head and Neck Cancer Diagnostic Market
    • 4.2.2: North American Head and Neck Cancer Diagnostic Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
  • 4.3: European Head and Neck Cancer Diagnostic Market
    • 4.3.1: European Head and Neck Cancer Diagnostic Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.3.2: European Head and Neck Cancer Diagnostic Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
  • 4.4: APAC Head and Neck Cancer Diagnostic Market
    • 4.4.1: APAC Head and Neck Cancer Diagnostic Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.4.2: APAC Head and Neck Cancer Diagnostic Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
  • 4.5: ROW Head and Neck Cancer Diagnostic Market
    • 4.5.1: ROW Head and Neck Cancer Diagnostic Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.5.2: ROW Head and Neck Cancer Diagnostic Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Type
    • 6.1.2: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Diagnosis
    • 6.1.3: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Treatment
    • 6.1.4: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by End Use
    • 6.1.5: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Head and Neck Cancer Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Head and Neck Cancer Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Head and Neck Cancer Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GE Healthcare
  • 7.2: Philips
  • 7.3: Siemens Healthineeer
  • 7.4: Merck
  • 7.5: Eli Lilly